ChainCatcher news, according to CoinDesk, the biopharmaceutical public company ATAI Life Sciences announced that it will adopt a Bitcoin financial strategy, planning to initially invest $5 million to purchase Bitcoin. Following this news, ATAI's stock price briefly rose.The company's chairman, Christian Angermayer, stated that the company plans to initially invest $5 million to purchase Bitcoin while retaining sufficient cash, short-term securities, and public equity to ensure the company's operating funds until 2027.

ChainCatcher news, YZi Labs announced that Jane He has become a general partner, leading biotechnology investments. Before joining YZi Labs, Jane was an investor and Chief Operating Officer at a hedge fund in Hong Kong, focusing on growth investments in biotechnology and innovation-driven industries.

ChainCatcher news, according to Cointelegraph, the charity Blockchain For Impact (BFI) founded by Polygon co-founder Sandeep Nailwal has committed to invest $90 million to advance biomedical research, drive healthcare innovation, and enhance climate resilience.In addition, BFI also plans to allocate an additional $200 million to support the development of healthcare startups, expand biomedical research, and strengthen public health systems.

ChainCatcher message, Coinbase International announced on platform X that the VVV-PERP, COOKIE-PERP, and BIO-PERP markets are now fully open for trading on Coinbase International Exchange and Coinbase Advanced. Limit, market, stop, and stop-limit orders are now available.

ChainCatcher news, according to the official announcement, Coinbase will launch perpetual futures contracts for Venice Token (VVV), Cookie DAO (COOKIE), and Bio Protocol (BIO) on March 13, 2025, at 17:30 (Beijing time) or later on Coinbase International and Coinbase Advanced. The new trading pairs include VVV-PERP, COOKIE-PERP, and BIO-PERP.

ChainCatcher news, according to Globe Newswire, the board of directors of the biotech company BioNexus Gene Lab Corp has approved a treasury strategy for Ethereum and released a related strategic white paper, allocating part of its funds to the Ethereum ecosystem.The company stated that this strategy aims to optimize financial management while exploring the potential applications of blockchain technology in the biotech field. The strategic white paper elaborates on how the company plans to leverage the smart contract capabilities and decentralized features of the Ethereum network to create new opportunities for its business development.

ChainCatcher news, the DeSci project Bio Protocol announced plans to create a decentralized BioAgents team capable of using new biotechnological tools by 2025, integrating BIO token economics to complete scientific tasks in longevity research, synthetic biology, and any BioDAO discipline. Bio Protocol will also equip each BioDAO with coordinating agents to allow scientists to focus on scientific research.Such agents will assist in various aspects of community governance, transaction processes, marketing, patient/researcher recruitment, multi-signature management, and more. The BIO token is a key way to incentivize and manage the growth of the BioAgent team. Fees generated by external partners using the BioAgent team will be burned.

ChainCatcher news, according to the official announcement, Binance has now completed the integration of Livepeer (LPT) on the Arbitrum One network and BIO Protocol (BIO) on the Solana network, and has opened deposit and withdrawal services.

ChainCatcher news, according to official news from Mask Network, the decentralized social protocol Mask Network has announced a significant restructuring of its ecosystem MaskDAO. In this restructuring, three Web3 social projects, Next.ID, Web3.Bio, and Firefly, will operate as independent projects, all under the management of MaskDAO.Mask Network founder Suji Yan stated that this spin-off will allow each project to independently expand their teams, promote product innovation, and conduct token economic simulations for fundraising.

ChainCatcher news, Nasdaq-listed company Quantum BioPharma announced an increase in its Bitcoin holdings worth $1 million. Last December, the company announced the launch of its Bitcoin strategy and purchased $1 million worth of Bitcoin. As of now, its total investment in Bitcoin has reached $2 million.Quantum BioPharma stated that its held cryptocurrencies will be stored by a compliant custodian, and it will explore cryptocurrency-based financing and other transactions in the future.

ChainCatcher news, Cycle Network has officially launched the Symbiotic mainnet, utilizing Verifiable State Aggregation (VSA) technology to build an efficient chain abstraction infrastructure. By combining Symbiotic's shared security model, Cycle provides users with a more secure and capital-efficient chain abstraction solution.Its unique three-layer architecture ensures the security of full-chain aggregated state verification, supporting over 20 blockchain networks, significantly simplifying cross-chain interactions while reducing capital requirements. Cycle will focus on expanding the supported blockchain networks, optimizing developer tools, and further promoting the development of Web3 applications.

ChainCatcher news, according to CoinDesk, Ripple announced a partnership with the Portuguese currency exchange provider Unicâmbio to support instant international payments between Portugal and Brazil.It is reported that Ripple payments use the XRP Ledger, allowing users to send and receive different currencies.

ChainCatcher news, according to official information, VitaDAO has initiated a new proposal to airdrop 2 million BIO tokens to VITA and VitaDAO IPT holders, with 50% of the airdrop available immediately and the remaining 50% to be distributed according to a 1-year linear unlocking plan.It is reported that this proposal is an improvement on VDP-161, adding Solana VITA holders as eligible participants, while excluding BIO Protocol Treasury or other bioDAO holders (those holding VITA in bioDAO) from the distribution.

ChainCatcher news, according to a report by Reuters, the biometric blockchain company Humanity Protocol announced the completion of a $20 million funding round led by Pantera Capital and Jump Crypto, with a fully diluted valuation of $1.1 billion. The company is developing a fingerprint-based authentication system and plans to expand its product applications in the coming months.Founder Terence Kwok stated that the protocol allows users to prove their human identity without disclosing personal information, helping to address issues such as bots, fake accounts, and online fraud. With concerns over AI deepfakes rising, digital identity verification companies are expected to gain more attention.Kwok revealed that Humanity Protocol is set to launch a cryptocurrency token, with final preparations currently underway. He also mentioned that the Trump administration supports the crypto industry and is committed to reducing heavy regulations, creating a business-friendly environment that will accelerate the development of blockchain solutions and attract investment.

ChainCatcher news, according to Tokenpost, Silk Road founder Ross Ulbricht is working on his first autobiographical documentary after receiving a presidential pardon from Donald Trump and being released on January 21.The documentary is led by filmmakers Jonah Tulis and Blake J. Harris, who have completed over 60 hours of interview content since 2019. The documentary is scheduled to be released in 2025 and will be produced and globally distributed by Submarine.

ChainCatcher message, according to the announcement image jointly released by multiple ecological projects such as ether.fi, Mellow, and Gauntlet, the staking protocol Symbiotic is expected to launch on the mainnet within this month.

ChainCatcher news, CureX announced that it will donate 20% of its CUX tokens to the BioV Foundation.CureX expressed gratitude for the technical support and funding assistance from Chulalongkorn University in Thailand, the Thai Royal Family, and Biov Laboratory in California, USA. The BioV Foundation will authorize its TRC-T biotechnology products and therapies to CureX, which has received legal certification in the United States, demonstrating significant efficacy in the treatment of malignant synovial sarcoma. CureX will promote advancements in DeSci medical technology through this authorization.At the same time, the BioV Foundation suggested that CureX airdrop the donated CUX tokens to community members supporting DeSci and biotechnology, and continue to contribute to the advancement of global biotechnology development.

ChainCatcher news, CCTV reporters learned that the U.S. Senate confirmed Marco Rubio as Secretary of State with a vote of 99 in favor and 0 against. This is the first senior cabinet official of the Trump administration to be confirmed by the Senate. Rubio has served as a Republican senator from Florida since 2011, and his nomination received support not only from Republicans but also from several Democratic senators.

ChainCatcher news, Trump's eldest son Donald Trump Jr. added "Meme Wars General" to his Instagram bio, meaning Meme Wars General.